Candipoz-GR 300 Posaconazole Gastro Resistant Tablets 300 mg

Description

Candipoz-GR 300 is an antifungal medication formulation containing 300 mg of the active agent posaconazole in a gastro-resistant tablet form. It belongs to the triazole class of drugs and functions by inhibiting the synthesis of ergosterol, an essential component for maintaining the integrity of fungal cell membranes. This high-strength tablet is primarily indicated for the prophylaxis (prevention) of invasive fungal infections, particularly Aspergillus and Candida, in severely immunocompromised patients at high risk. The “gastro-resistant” coating is designed to ensure the tablet passes intact through the stomach to be absorbed in the intestines, offering improved bioavailability compared to oral suspensions.